freeze-thaw is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-07. Numbers and descriptions here follow the published literature rather than marketing material.
Receiving a peptide shipment requires immediate inspection of the packaging and temperature indicators. Any deviation from the specified cold chain should be documented and investigated. Upon arrival, solid peptides are generally kept at -20°C, whereas liquid formulations are stored at -80°C. Vials should be kept upright and protected from light. Repeated warming and cooling of the entire container is avoided by preparing smaller working aliquots. A log of lot numbers, receipt dates, and storage locations supports traceability and quality control.
Reconstitution is a critical handling step. The appropriate solvent—often sterile water, phosphate-buffered saline, or a water-acetonitrile mixture—is chosen based on peptide solubility. Adding solvent gently down the vial wall and swirling, rather than vortexing, reduces foaming and shear stress. The resulting solution should be clear; visible particles indicate incomplete dissolution or contamination. Concentration is recorded accurately because it affects subsequent use. If the peptide is not fully soluble, a small amount of organic solvent or a different buffer may be required, but this changes the final composition.
Receiving a peptide begins with recording its identity, lot number, quantity, and arrival condition. Dry material is often kept in sealed containers with desiccant and an inert headspace to limit moisture and oxygen. Containers should be compatible with the peptide and solvent; some peptides adsorb to certain plastics or glass. Labels should include date, concentration, solvent, and storage location. A centralized inventory with temperature logs helps prevent loss and mix-ups.
Reconstitution involves adding a solvent to dry peptide, often water or a buffered solution. The chosen liquid should match the peptide's solubility and intended assay, and it should be free of contaminants. Gentle mixing or inversion reduces foaming and shear, which can damage some peptides. If the peptide does not dissolve readily, adjusting pH or using a small amount of organic co-solvent may help. The final solution is typically clarified before use in analytical or laboratory procedures.
After reconstitution, solutions are usually divided into single-use aliquots to limit repeated handling. Each aliquot is stored at a temperature appropriate for the peptide, with -20 °C or -80 °C common for longer-term laboratory storage. Freeze-thaw cycles are minimized because they can cause aggregation, precipitation, or loss of activity. Temperature monitoring and documented storage conditions support reproducibility across experiments. When a peptide is removed from storage, it is typically allowed to equilibrate before opening to reduce condensation.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (lyophilized) | -20°C | Stable for months to years; avoid frost-free freezers |
| Storage temperature (solution) | -80°C | Single-use aliquots preferred; avoid repeated freeze-thaw |
| Reconstitution solvent | Sterile water or buffer | Choice depends on peptide solubility and application |
| Container material | Glass or polypropylene | Low protein-binding surfaces reduce adsorption |
| Shipping condition | Dry ice | Insulated packaging maintains cold chain during transit |
== Clinical significance == At birth, the bones of the skull do not meet. If certain bones of the skull grow too fast, then craniosynostosis (premature closure of the sutures) may occur. This can result in skull deformities. If the lambdoid suture closes too soon on one side, the skull will appear twisted and asymmetrical, a condition called "plagiocephaly". Plagiocephaly refers to the shape and not the condition. The condition is craniosynostosis. The lambdoid suture can be damaged by a fall backward.
Fluid pressure is most often the compressive stress at some point within a fluid. (The term fluid refers to both liquids and gases – see below for more information specifically about liquid pressure or gas pressure.) Fluid pressure occurs in one of two situations:
He criticised Israel for its attacks on government and civilians and expressed gratitude for American, Arab, and Turkish mediators for de-escalating the conflict and said that "the Israeli entity resorted to a wide-scale targeting of civilian and government facilities", adding that it led to a "significant complication of the situation and pushed matters to a large-scale escalation". On 16 July 2025, US Secretary of State Marco Rubio stated that the United States was making progress for a ceasefire agreement including Israel, saying "We hope to see some real progress to end what you've been seeing over the last couple of hours", as he addressed reporters at the Oval Office. According to a Turkish security source, Turkish intelligence officers held talks with Syrian Druze leaders for securing the ceasefire. İbrahim Kalın, the director of the Turkish National Intelligence Organization, also held discussions with his Israeli, American and Syrian counterparts, as well as Ahmed al-Sharaa. A joint "Gulf-Arab-Turkish" statement reaffirmed their support for Syrian integrity and "welcomed" al-Sharaa's commitment to hold to account fighters who took part in "abuses". According to the spiritual leadership of the Druze in Syria, the agreement signed for a ceasefire from 19 July included a number of key steps intended to bring about calm and an end to the conflicts in the area.
Sources: en.wikipedia.org
Two isolated fossilized footprints have been tentatively assigned to T. rex. The first was discovered at Philmont Scout Ranch, New Mexico, in 1983 by American geologist Charles Pillmore. Originally thought to belong to a hadrosaurid, examination of the footprint revealed a large 'heel' unknown in ornithopod dinosaur tracks, and traces of what may have been a hallux, the dewclaw-like fourth digit of the tyrannosaur foot. The footprint was published as the ichnogenus Tyrannosauripus pillmorei in 1994, by Martin Lockley and Adrian Hunt. Lockley and Hunt suggested that it was very likely the track was made by a T. rex, which would make it the first known footprint from this species. The track was made in what was once a vegetated wetland mudflat. It measures 83 centimeters (33 in) long by 71 centimeters (28 in) wide. A second footprint that may have been made by a Tyrannosaurus was first reported in 2007 by British paleontologist Phil Manning, from the Hell Creek Formation of Montana. This second track measures 72 centimeters (28 in) long, shorter than the track described by Lockley and Hunt. Whether or not the track was made by Tyrannosaurus is unclear, though Tyrannosaurus is the only large theropod known to have existed in the Hell Creek Formation. A set of footprints in Glenrock, Wyoming dating to the Maastrichtian stage of the Late Cretaceous and hailing from the Lance Formation were described by Scott Persons, Phil Currie and colleagues in 2016, and are believed to belong to either a juvenile T. rex or Nanotyrannus lancensis.
== Other animals == In dogs, OI is an autosomal recessive condition, meaning that dogs with two copies of the allele will be affected. Many breed organizations and veterinarians offer OI tests to tell if a dog is a carrier of OI. To prevent OI, dogs who are heterozygous for OI should not be bred. Naturally occurring mutations causing OI have been found in Golden Retrievers, Dachshunds, and Beagles. OI has also been identified in zebrafish and mice. Although dogs, mice, fish, and humans are not genetically identical, some of these animal models have been officially recognized to represent the varying types of OI in humans. For example, homozygous oim/oim mice experience spontaneous bone fractures, small body size, and kyphosis, making them a model of OI type III. Meanwhile, heterozygous oim/+ mice appear normal but have bones which are quite a bit weaker than wild mice, making them a model for OI type I. As in human OI, the location on the gene which is mutated affects the severity of resulting disease—the G859C Col1a1 mouse is a model for OI type II as affected mice all die in the perinatal period. Animal testing on identified animal models may lead to human therapies for OI.
==== Properties ==== The significant disadvantages of hide glue—its thermal limitations, short open time, and vulnerability to micro-organisms—are offset by several advantages. Hide glue joints are reversible and repairable. Recently glued joints will release easily with the application of heat and steam. Hide glue sticks to itself, so the repairer can apply new hide glue to the joint and reclamp it. In contrast, PVA glues do not adhere to themselves once they are cured, so a successful repair requires removal of the old glue first—which usually requires removing some of the material being glued. Hide glue creates a somewhat brittle joint, so a strong shock will often cause a very clean break along the joint. In contrast, cleaving a joint glued with PVA will usually damage the surrounding material, creating an irregular break that is more difficult to repair. This brittleness is taken advantage of by instrument makers. For example, instruments in the violin family require periodic disassembly for repairs and maintenance. The top of a violin is easily removed by prying a palette knife between the top and ribs, and running it all around the joint. The brittleness allows the top to be removed, often without significant damage to the wood. Regluing the top only requires applying new hot hide glue to the joint. If the violin top were glued on with PVA glue, removing the top would require heat and steam to disassemble the joint (causing damage to the varnish), then wood would have to be removed from the joint to ensure no cured PVA glue was remaining before regluing the top.
In 1963, promethium(III) fluoride was used to make promethium metal. Provisionally purified from impurities of samarium, neodymium, and americium, it was put into a tantalum crucible which was located in another tantalum crucible; the outer crucible contained lithium metal (10 times excess compared to promethium). After creating a vacuum, the chemicals were mixed to produce promethium metal:
Sources: en.wikipedia.org
Common solvents include sterile water, phosphate-buffered saline, and water-acetonitrile mixtures. The choice depends on the peptide's solubility profile and the buffer compatibility for the intended application. Manufacturers often provide a recommended solvent on the product information sheet.
Solutions are typically stored at -80°C in single-use aliquots to avoid repeated freeze-thaw cycles. They should be protected from light and kept in low-binding containers. Some peptides require a carrier protein or cryoprotectant to prevent adsorption and aggregation.
Records should include the lot number, date received, storage temperature, and any handling steps. A log of freeze-thaw cycles and aliquot preparation helps track stability. This documentation supports traceability and quality control.
Dry peptides are generally kept in sealed, desiccated containers at low temperature, often -20 °C or colder. Protection from light, moisture, and oxygen helps slow degradation. The exact condition depends on the peptide sequence and supplier guidance.